POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
Clinical safety rating
cautionComprehensive clinical and safety monograph for POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER (POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER).
Potassium is the major intracellular cation; it is essential for maintenance of intracellular tonicity, transmission of nerve impulses, contraction of cardiac, skeletal, and smooth muscle, and maintenance of normal renal function. Dextrose is a monosaccharide that provides caloric support. Lactated Ringer's solution contains sodium, chloride, potassium, calcium, and lactate in a balanced electrolyte solution; lactate is metabolized to bicarbonate in the liver, providing an alkalinizing effect.
| Metabolism | Potassium is not metabolized; it is excreted primarily by the kidneys. Dextrose is metabolized via glycolysis and the citric acid cycle. Lactate is converted to glucose via gluconeogenesis or oxidized to carbon dioxide and water. |
| Excretion | Primarily renal (>90% excreted unchanged by kidneys); minimal fecal/biliary elimination (<5%) |
| Half-life | Not applicable (endogenous ion with tight homeostatic regulation; administered potassium is rapidly distributed and eliminated, half-life of distribution ~1-2 hours, but terminal elimination depends on renal function and body stores) |
| Protein binding | Negligible (<5%) |
| Volume of Distribution | 0.14-0.2 L/kg (primarily intracellular distribution; total body water) |
| Bioavailability | Oral: 100% (as potassium salt, but absorption may be limited by gastrointestinal factors; intravenous: 100% |
| Onset of Action | Intravenous: within minutes (immediate effect on serum potassium); oral: 30-60 minutes |
| Duration of Action | Intravenous: 2-4 hours (duration of effect on serum potassium followed by redistribution); prolonged with continuous infusion |
| Molecular Weight | 74.55 (KCl); Dextrose: 180.16; Lactate: 89.07 |
Potassium chloride 20 mEq in dextrose 5% and lactated Ringer's solution, intravenous infusion over at least 1 hour, typically given as 20 mEq per dose, administered no faster than 10 mEq/h. Frequency depends on serum potassium levels, typically every 4-6 hours.
| Dosage form | INJECTABLE |
| Renal impairment | For GFR 30-50 mL/min: reduce dose by 50% or extend interval. For GFR <30 mL/min: contraindicated or use with extreme caution, maximum dose 20 mEq per day. |
| Liver impairment | Child-Pugh class A: no adjustment required. Child-Pugh class B or C: reduce dose by 50% and monitor serum potassium closely due to risk of hyperkalemia. |
| Pediatric use | Dose: 0.5-1 mEq/kg/dose, IV infusion at a rate not exceeding 0.5 mEq/kg/h. Maximum single dose: 20 mEq. Frequency based on serum potassium deficits. |
| Geriatric use | Start at lower end of dosing range (e.g., 10 mEq per dose) due to decreased renal function. Infusion rate not to exceed 10 mEq/h. Monitor renal function and serum potassium frequently. |
| 1st trimester | Potassium chloride and dextrose/lactated Ringer's are generally considered safe in pregnancy when clinically indicated. However, avoid overcorrection of hypokalemia as hyperkalemia may pose risks to the fetus. Use with caution. |
| 2nd trimester | Same as T1. Monitor serum potassium and glucose levels. |
| 3rd trimester | Same as T1. May be used for maintenance or replacement therapy; consider potential for fluid overload. |
Clinical note
Comprehensive clinical and safety monograph for POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER (POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER).
| Placental transfer | Potassium crosses the placenta by active transport; dextrose and lactate cross freely. No specific harm documented at therapeutic doses. |
| Breastfeeding | Potassium chloride and components of lactated Ringer's are normal constituents of breast milk. Dextrose may increase milk glucose slightly. Use is considered compatible with breastfeeding. Monitor infant for electrolyte disturbances if large doses are given. |
| Lactation Rating | Safe |
| Teratogenic Risk | Potassium chloride is a physiological electrolyte. No teratogenic effects are expected based on mechanism and clinical data. Use during pregnancy is considered safe when clinically indicated. |
| Fetal Monitoring | Monitor maternal serum potassium, glucose, and electrolyte levels. Fetal heart rate monitoring is not routinely required but may be indicated if maternal electrolyte disturbances occur. |
| Fertility Effects | No known adverse effects on fertility. Potassium chloride is not associated with reproductive toxicity in animal or human studies. |
■ FDA Black Box Warning
Concentrated potassium solutions must be diluted before administration. Rapid infusion of potassium may cause fatal hyperkalemia.
| Serious Effects |
HyperkalemiaHyperglycemiaSevere renal impairmentAddison's diseaseAcute dehydrationConcomitant use with potassium-sparing diureticsAnuria or oliguriaHypersensitivity to any component
| Precautions | Use with caution in patients with renal impairment, heart disease, or conditions predisposing to hyperkalemia, Monitor serum potassium levels frequently during therapy, Avoid rapid infusion; may cause hyperkalemia and cardiac arrhythmias, Use with caution in patients with metabolic alkalosis or hyperlactatemia |
| Food/Dietary | Avoid excessive intake of potassium-rich foods (e.g., bananas, oranges, spinach) unless advised by your doctor. Salt substitutes often contain potassium chloride and should be avoided. Maintain adequate fluid intake as directed. |
| Clinical Pearls | This combination is used for correction of hypokalemia with concurrent fluid and electrolyte depletion. Monitor serum potassium closely, especially in renal impairment. Do not administer undiluted; this is a premixed solution. Avoid rapid infusion to prevent hyperkalemia. Dextrose may cause hyperglycemia; monitor blood glucose. Lactated Ringer's is contraindicated in lactic acidosis. |
| Patient Advice | This medication is used to treat low potassium levels and provide fluids and electrolytes. · Notify your healthcare provider if you experience muscle weakness, irregular heartbeat, or tingling sensations. · Do not stop the infusion suddenly; the dose will be adjusted based on your blood tests. · If you have diabetes, monitor your blood sugar levels closely as this solution contains dextrose. |
Loading safety data…